Welltower Inc. (NYSE:WELL) is a prominent real estate investment trust, or REIT, that strategically invests in healthcare infrastructure. The company primarily focuses on essential properties like senior housing and outpatient medical facilities. It is widely considered a leading REIT in its sector, recognized for its strong fundamentals and disciplined management of its finances.
An analyst at UBS has raised their price target for Welltower to $249.00 from a previous target of $240.00. When this update occurred, the stock was trading at $216.91. This new target represents a potential increase of 14.79% from that price, reflecting a strong positive outlook on the company's future performance.
This optimism is supported by strong financial results. For the first quarter of 2026, Welltower reported normalized funds from operations (FFO) of $1.47 per share, successfully beating analyst estimates. FFO is a crucial key performance measure for REITs that effectively shows the cash generated from their operations. Total revenues reached $3.35 billion, marking a significant 38.3% year-over-year increase.
The company's Senior Housing Operating (SHO) portfolio is identified as a major driver of this growth. This segment saw a substantial 22.1% increase in same-store Net Operating Income (NOI), a critical metric used to analyze the profitability of real estate investments. This impressive performance was further supported by an improved occupancy rate of 89.0%, as highlighted by industry insights from Zacks.
However, a Seeking Alpha analysis points out that Welltower's stock trades at a high valuation. Its Price to FFO (P/FFO) multiple stands at 33x, which is over 30% above its historical average. This valuation is also 131% above its peers, suggesting the stock's price may be considerably high compared to its operational earnings.
